Neutrophil Gelatinase-associated Lipocalin as a New Biomarker to Detect Acute Kidney Injury in Postoperative Cardiac Surgery

• Conditions: Cardiac Surgery

• Registration Number: NCT01594788
• Lead Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Brief Summary

Observational study aimed to test the ability of Neutrophil Gelatinase-associated Lipocalin (NGAL) concentration in blood and urine to predict and diagnose early acute renal failure (ARF) in patients after cardiac surgery with/without Cardiopulmonary bypass (CPB).

Detailed Description

Not available

Study Timeline

• Study Start: 2011-04
• Status Verified: 2012-01
• Study First Submitted: 2012-05-07
• Study First Submitted QC: 2012-05-08
• Last Update Submitted: 2012-05-08
• Study First Posted: 2012-05-09
• Last Update Posted: 2012-05-09
• Study Completion: 2012-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 340

Inclusion Criteria

• Men or women over 18 years proposed for cardiac surgery with / without CPB.
• Accepting to participate in the study, with informed consent signed by the patient, guardian or family member.

Exclusion Criteria

• Patients < 18 years.
• Patients do not agree to participate in the study.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Hospital de la Santa Creu i Sant Pau; 🇪🇸 Barcelona, Spain